Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional SamplingWayne Brisbane, Leonard S. Marks, Alan Priester et al.|European Urology|2022Cited by 169
Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomesMamdouh Aker, Leonard S. Marks, Wayne Brisbane et al.|Cancer Medicine|2023Cited by 25
Genetic factors associated with prostate cancer conversion from active surveillance to treatmentYu Jiang, Travis J. Meyers, Adaeze A. Emeka et al.|Human Genetics and Genomics Advances|2021Cited by 23
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J. Meyers, Adaeze A. Emeka et al.|medRxiv|2021Cited by 14
Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomesWayne Brisbane, Leonard S. Marks, Alan Priester et al.|BJUI Compass|2024Cited by 12